510(k) · Cleared
ClearedSynoss Synthetic Bone Graft Material
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Collagen Matrix, Inc. · LYC Bone Grafting Material, Synthetic
Cleared on Oct 18, 2007 as substantially equivalent to K043034 (Collagen Matrix, Inc., 2005) after a 52-day review. Its family tree reaches back 3 generations to 1987. 3 later devices descend from it.
- Decided
- Oct 18, 2007
- Review
- 52 days
- Class
- Class II
- Product code
- LYC
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 3 generations to K871773 (1987). 9 ancestors in all. 3 later devices descend from it, 3 citing it directly.
- Root · 3 generations backK871773 Bio-Oss Pure Nat Hydroxyapatite Endoss ImplantGeistlich-Pharma · 1987
- 2 generations backK033815 Bio-Oss, Bio-Oss Blocks and Bio-Oss CollagenGeistlich-Pharma · 2004
- 1 generation backK043034 Osteoguide Anorganic Bone Mineral ProductsCollagen Matrix, Inc. · 2005 · Recalled
- This deviceK072397 Synoss Synthetic Bone Graft MaterialCollagen Matrix, Inc. · 2007
- Descendant · cites it directly · 0 of its ownK192597 Cytrans GranulesGC America, Inc. · 2020
- Descendant · cites it directly · 0 of its ownK090793 Bongros HABioalpha, Inc. · 2009
- Descendant · cites it directly · 0 of its ownK083742 Synoss Collagen Synthetic Mineral-Collagen Bone Graft MatrixCollagen Matrix, Inc. · 2009
Most influential descendants
Showing 3 of 3 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K871773 | Bio-Oss Pure Nat Hydroxyapatite Endoss Implant | Geistlich-Pharma | 1987 | — |
| −2 | K033815 | Bio-Oss, Bio-Oss Blocks and Bio-Oss Collagen | Geistlich-Pharma | 2004 | — |
| −1 | K043034 | Osteoguide Anorganic Bone Mineral Products | Collagen Matrix, Inc. | 2005 | 3 |
| 0 (this device) | K072397 | Synoss Synthetic Bone Graft Material | Collagen Matrix, Inc. | 2007 | — |
| +1 | K192597 | Cytrans Granules | GC America, Inc. | 2020 | — |
| +1 | K090793 | Bongros HA | Bioalpha, Inc. | 2009 | — |
| +1 | K083742 | Synoss Collagen Synthetic Mineral-Collagen Bone Graft Matrix | Collagen Matrix, Inc. | 2009 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1992 | 1 | 0 |
| 1995 | 2 | 0 |
| 1998 | 2 | 0 |
| 2000 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2009 | 2 | 0 |
| 2020 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LYC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LYC device
- #1 K253317 Cytrans™ Elashieldscore 14.3 · 10 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K043034 | Osteoguide Anorganic Bone Mineral ProductsSummary page 1…LYC Class II Predicate Device(s): OsteoGuideTm Anorganic Bone Mineral Products K043034 Description of the Device SynOSSTM Synthetic Bone Graft Material is an osteoconductive calcium phosphate based bone graft mater… | 2005 |
What descends from it? (3)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 20 years and passes through 2 companies; a new generation was cleared every 2.2 years on median.
- 1 of the 9 ancestors has a recall of any class.
- Of its descendants, K192597 (GC America, Inc., 2020) has gone furthest, with 0 descendants of its own.
- 8 other devices also cite its predicate K043034.
How does its category compare?
All LYC devicesLYC Bone Grafting Material, Synthetic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · LYC
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LYC
267in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LYC
1in 2018
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LYC
2in 2025
MAUDE reports naming product code LYC, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 13 | 80 | 0 | 23 |
| 2008 | 8 | 73 | 0 | 25 |
| 2009 | 14 | 100 | 1 | 25 |
| 2010 | 13 | 164 | 2 | 28 |
| 2011 | 9 | 224 | 0 | 21 |
| 2012 | 5 | 120 | 2 | 10 |
| 2013 | 2 | — | 0 | 12 |
| 2014 | 1 | — | 0 | 9 |
| 2015 | 0 | — | 0 | 14 |
| 2016 | 2 | — | 2 | 140 |
| 2017 | 0 | — | 0 | 19 |
| 2018 | 0 | — | 1 | 14 |
| 2019 | 0 | — | 0 | 15 |
| 2020 | 3 | 156 | 0 | 5 |
| 2021 | 0 | — | 0 | 12 |
| 2022 | 2 | — | 0 | 6 |
| 2023 | 0 | — | 0 | 9 |
| 2024 | 0 | — | 0 | 6 |
| 2025 | 3 | 267 | 0 | 2 |
| 2026 | 3 | 266 | 0 | — |
What is it indicated for?
SynOss Synthetic Bone Graft Material is intended for use in dental surgery. The products may be used in surgical procedures such as:
* Augmentation or reconstructive treatment of alveolar ridge
* Filling of periodontal defects
* Filling of defects after root resection, apicocectomy, and cystectomy
* Filling of extraction sockets to enhance preservation of the alveolar ridge
* Elevation of maxillary sinus floor
* Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR)
* Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K072397 · printed Nov 6, 2026
Cite this page
510(k) Report. “K072397: Synoss Synthetic Bone Graft Material.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K072397
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026